Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Inorganic Nitrate Supplementation in PAD
NCT05036213Phase 1Unknown
- Sponsor
- University of Virginia
- Start
- Feb 2020
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial (2 arms), sponsored by University of Virginia. Primary endpoint: Phosphocreatine recovery time constant. Status: unknown.
Beyond the preview
Go deeper on NCT05036213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05036213.